Lyell Immunopharma, Inc. — SC 13G Filings
7 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Lyell Immunopharma, Inc. (LYEL), sorted by most recent first. Each row links to the full filing on EdgarLookup. Lyell Immunopharma, Inc. has filed 7 SC 13G documents with the SEC since 2020. To view all SEC filings by Lyell Immunopharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | SC 13G | 0001104659-24-113135 | Oct 31, 2024 | — |
| SC 13G | — | 0001086364-24-005606 | Jan 29, 2024 | — |
| SC 13G | SCHEDULE 13G | 0001104659-23-016396 | Feb 9, 2023 | — |
| SC 13G | SC 13G | 0001193125-22-041763 | Feb 14, 2022 | — |
| SC 13G | SC 13G | 0001193125-22-041692 | Feb 14, 2022 | — |
| SC 13G | ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G | 0001072613-22-000148 | Feb 14, 2022 | — |
| SC 13G | SC 13G | 0001104659-22-020368 | Feb 11, 2022 | — |